Affinity-Purified Escherichia Coli J5 Lipopolysaccharide-Specific Igg Protects Neutropenic Rats Against Gram-Negative Bacterial SepsisA. K. Bhattacharjee, Alan S. Cross, Steven M. Opal et al.|The Journal of Infectious Diseases|1994Cited by 43
Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsisAlan S. Cross, Apurba K. Bhattacharjee, Steven M. Opal et al.|Vaccine|2003Cited by 32
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjectsAlan S. Cross, Apurba K. Bhattacharjee, Christian Hüber et al.|Vaccine|2003Cited by 31
Radiotherapy and Receptor Tyrosine Kinase Inhibition for Solid Cancers (ROCKIT): A Meta-Analysis of 13 StudiesLeila T. Tchelebi, Nicholas G. Zaorsky, Joseph J. Drabick et al.|JNCI Cancer Spectrum|2021Cited by 22